Home/Filings/4/0000874716-25-000030
4//SEC Filing

Underberg Sharon E. 4

Accession 0000874716-25-000030

CIK 0000874716other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 9:44 PM ET

Size

25.6 KB

Accession

0000874716-25-000030

Insider Transaction Report

Form 4
Period: 2025-02-13
Underberg Sharon E.
EVP, GC & Corporate Secretary
Transactions
  • Award

    Incentive Stock Option (right-to-buy)

    2025-02-13+217217 total
    Exercise: $459.76Exp: 2035-02-12Common Stock (217 underlying)
  • Award

    Common Stock

    2025-02-14+1375,778.945 total
  • Award

    Common Stock

    2025-02-14+1735,951.945 total
  • Award

    Common Stock

    2025-02-14+1766,127.945 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-141370 total
    Common Stock (137 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-14173173 total
    Common Stock (173 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-14176352 total
    Common Stock (176 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-14218652 total
    Common Stock (218 underlying)
  • Award

    Common Stock

    2025-02-14+2186,345.945 total
  • Tax Payment

    Common Stock

    2025-02-14$444.53/sh219$97,3526,126.945 total
  • Award

    Non-Qualified Stock Option (right-to-buy)

    2025-02-13+4,5044,504 total
    Exercise: $459.76Exp: 2035-02-12Common Stock (4,504 underlying)
  • Award

    Restricted Stock Unit

    2025-02-13+1,0601,060 total
    Common Stock (1,060 underlying)
Footnotes (8)
  • [F1]Includes a total of 47 shares purchased under the Issuer Employee Stock Purchase Plan on March 29, 2024, June 28, 2024, September 30, 2024 and December 31, 2024.
  • [F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
  • [F3]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
  • [F4]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
  • [F5]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2022.
  • [F6]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2023.
  • [F7]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
  • [F8]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2025.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001630353

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 9:44 PM ET
Size
25.6 KB